共 59 条
[1]
Vergis EN(2001)Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia Ann Intern Med 135 484-492
[2]
Hayden MK(2008)Infection control experience in a cooperative care center for transplant patients Infect Control Hosp Epidemiol 29 424-429
[3]
Chow JW(2007)Colonization, bloodstream infection and mortality caused by vancomycin-resistant entercoccus early after allogeneic hematopoietic stem cell transplant Biol Blood Marrow Transplant 13 615-621
[4]
Nusair A(2007)A population-based investigation of invasive vancomycin-resistant enterococcus infection in metropolitan Atlanta, Georgia, and predictors of mortality Infect Control Hosp Epidemiol 28 983-991
[5]
Jourdan D(2009)Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome J Infect 58 182-190
[6]
Medcalf S(2008)Impact of the more potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant enterococcus bacteremia CID 46 30-36
[7]
Weinstock DM(2000)A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible entercoccal bacteremia Diagn Microbiol Infect Dis 36 145-158
[8]
Conlon M(2009)Daptomycin therapy for vancomycin-resistant entercoccal bacteremia: a retrospective case series of 30 patients Pharmacotherapy 29 792-799
[9]
Iovino C(1997)Mechanism of action of oxalidinones: effects of linezolid and eperezolid on translation reactions Antimicrob Agents Chemother 41 2132-2136
[10]
Camins BC(2003)Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia Ann Oncol 14 795-801